Study Reveals How Damaged Fat Cells Contribute to Diabetes Risk
Fat tissue, often perceived negatively, is recognized as an active organ essential for various bodily functions, including energy storage and metabolic regulation. While excess fat is known to increase the risk of diabetes and heart disease, the loss of healthy fat can also pose significant health risks. This paradox is particularly evident in conditions like familial partial lipodystrophy type 2 (FPLD2), where abnormal fat loss leads to diabetes and metabolic complications. Dr. Elif Oral, a clinician and Professor in the Division of Metabolism, Endocrinology and Diabetes, has dedicated her research to understanding how pathological fat loss affects metabolism and to improving treatment for lipodystrophy syndromes. Collaborating with Dr. Ormond MacDougald and a team of researchers, Dr. Oral investigated the mechanisms underlying the dysfunction of fat tissue in patients with FPLD2. The research utilized a mouse model to deactivate the lamin A/C gene in adipocytes, mirroring the genetic mutations found in affected individuals. The findings revealed significant alterations in gene activity that hindered fat cells from effectively processing and storing lipids. Concurrently, both adipocytes and immune cells within the fat tissue transitioned into a pro-inflammatory state. The mitochondria in these fat cells also exhibited dysfunction, which is critical as mitochondria are responsible for energy production. The combination of these factors creates an unhealthy environment for fat tissue, leading to its eventual deterioration. The loss of healthy adipose tissue disrupts the body's ability to manage lipids and regulate metabolic hormones, contributing to severe conditions such as diabetes and fatty liver disease. Dr. Oral emphasized the importance of healthy fat in maintaining metabolic health, stating that while Type 2 diabetes is often viewed as a pancreatic issue, it is equally a problem of fat cell health. The researchers aim to identify new therapeutic strategies to protect adipose tissue from deterioration, thereby mitigating metabolic damage. This study underscores the necessity of collaboration between clinical researchers and basic scientists, as well as the invaluable role of patient involvement in developing effective therapies. The insights gained from this research could pave the way for innovative approaches to prevent diabetes and improve metabolic health.




